Arena Pharmaceuticals, Inc. - Common Stock (NQ:ARNA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 10, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arena Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >

40 Stocks Moving In Monday's Mid-Day Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals (NASDAQ:ARNA...

Via Benzinga

AMC, GME: What Investors Are Saying as the Top 2 Meme Stocks Tumble Today ↗

December 13, 2021

AMC Entertainment (AMC) and GameStop (GME) are taking a beating today and traders of the meme stocks are reacting on social media.

Via InvestorPlace

GPRO Stock Price Prediction: Why One Analyst Is Raising Its GoPro Target ↗

December 13, 2021

GoPro (GPRO) stock is rising higher on Monday thanks to a new upgrade and price prediction from Wedbush analyst Alicia Reese.

Via InvestorPlace

How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal ↗

December 13, 2021

The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash...

Via Talk Markets

Topics Cannabis

ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today ↗

December 13, 2021

Arena Pharmaceuticals (ARNA) stock is flying higher on Monday thanks to a huge $6.7 billion acquisition deal with Pfizer (PFE).

Via InvestorPlace

How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal ↗

December 13, 2021

Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e...

Via Benzinga

Topics Cannabis

Pfizer Stock Up, Arena Stock Soars On $6.7 Billion Merger Deal ↗

December 13, 2021

Pfizer stock was up while Arena stock soared Monday after Pfizer announced it is acquiring Arena for $100 a share in a $6.7 billion deal.

Via Investor's Business Daily

Why Pfizer Shares Are Trading Higher Today ↗

December 13, 2021

Pfizer Inc (NYSE: PFE) is trading higher Monday after UBS upgraded the stock and raised its price target. UBS analyst Colin Bristow upgraded Pfizer from a Neutral rating...

Via Benzinga

Why Arena Pharmaceuticals Stock Is Soaring Today ↗

December 13, 2021

Arena Pharmaceuticals Inc (NASDAQ: ARNA) is soaring Monday morning after Pfizer Inc (NYSE: PFE) announced it would acquire the company for $100 per share. The all-cash...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals ↗

December 13, 2021

Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The S&P also fell, dropping 0.46% to 4,690.48. The U.S....

Via Benzinga

Topics Stocks

Arena Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Arena Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ARNA

December 13, 2021

From Halper Sadeh LLP

Via Business Wire

Investors Appear to Get Defensive as the Consumer Staples Sector Breakout on Friday ↗

December 13, 2021

Equity index futures are pointing slightly higher on Monday morning as investors appear to be a little tentative ahead of the Fed meeting later this week. Friday’s Consumer...

Via Benzinga

Topics Economy

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals (NASDAQ:ARNA) stock moved upwards by 91.22% to $95.5 during Monday's pre-market session. The company's market cap stands at $5.8...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 13, 2021

Welcome back, investor! With our return from the weekend comes a dive into the biggest pre-market stock movers for Monday!

Via InvestorPlace

After Blood Cancer, Pfizer Now Bolsters Its Inflammatory Diseases Pipeline With $6.7B Arena Deal ↗

December 13, 2021

Pfizer Inc (NYSE: PFE) has agreed to acquire Arena Pharmaceuticals Inc (NASDAQ: ARNA), a clinical-stage company developing therapies to treat several immuno-...

Via Benzinga

Pfizer to Acquire Arena Pharmaceuticals

December 13, 2021

From Pfizer Inc.

Via Business Wire

Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod CULTIVATE Study A

November 19, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 ↗

December 08, 2021

Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...

Via Benzinga

Chart: How Have Cannabis Industry Sectors Performed This Year And What Are Their Valuation Multiples? Do They Make Sense? ↗

November 18, 2021

Viridian Capital Advisors breaks the cannabis industry down into 12 sub sectors for purposes of tracking capital raises, M&A activity, valuatio...

Via Benzinga

Topics Cannabis

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 16, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals, inc (ARNA) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

ARNA earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Arena Reports Third Quarter Financial Results and Key Program Updates

November 04, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 21, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Corporate Update on November 4

October 14, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 17, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Arena Pharmaceuticals to Host Virtual R&D Investor Calls and Participate in Upcoming September Investor Conferences

September 02, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.